GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 2013
    In:  BMC Bioinformatics Vol. 14, No. S17 ( 2013-10)
    In: BMC Bioinformatics, Springer Science and Business Media LLC, Vol. 14, No. S17 ( 2013-10)
    Type of Medium: Online Resource
    ISSN: 1471-2105
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2013
    detail.hit.zdb_id: 2041484-5
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 2002
    In:  Glycoconjugate Journal Vol. 19, No. 7-9 ( 2002), p. 527-535
    In: Glycoconjugate Journal, Springer Science and Business Media LLC, Vol. 19, No. 7-9 ( 2002), p. 527-535
    Type of Medium: Online Resource
    ISSN: 0282-0080
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2002
    detail.hit.zdb_id: 1483682-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 1990
    In:  In Vitro Cellular & Developmental Biology Vol. 26, No. 4 ( 1990-4), p. 318-324
    In: In Vitro Cellular & Developmental Biology, Springer Science and Business Media LLC, Vol. 26, No. 4 ( 1990-4), p. 318-324
    Type of Medium: Online Resource
    ISSN: 0883-8364 , 1475-2689
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 1990
    detail.hit.zdb_id: 1497464-2
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: SSRN Electronic Journal, Elsevier BV
    Type of Medium: Online Resource
    ISSN: 1556-5068
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2010
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    Springer Science and Business Media LLC ; 2017
    In:  BMC Cancer Vol. 17, No. 1 ( 2017-12)
    In: BMC Cancer, Springer Science and Business Media LLC, Vol. 17, No. 1 ( 2017-12)
    Type of Medium: Online Resource
    ISSN: 1471-2407
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2017
    detail.hit.zdb_id: 2041352-X
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    Wiley ; 1996
    In:  IUBMB Life Vol. 40, No. 1 ( 1996-9), p. 13-20
    In: IUBMB Life, Wiley, Vol. 40, No. 1 ( 1996-9), p. 13-20
    Type of Medium: Online Resource
    ISSN: 1521-6543
    Language: English
    Publisher: Wiley
    Publication Date: 1996
    detail.hit.zdb_id: 2009952-6
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2009
    In:  Cancer Research Vol. 69, No. 23_Supplement ( 2009-12-01), p. B52-B52
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 69, No. 23_Supplement ( 2009-12-01), p. B52-B52
    Abstract: Annexin A6 (ANXA6) is a member of a family of Ca2+-dependent phospholipid-binding proteins capable of associating with negatively charged membranes in its Ca2+-bound state. Although the functions of this protein are yet to be clearly defined, various physiological roles have been proposed, including a role in the regulation of cell growth and tumorigenesis. We previously showed that ANXA2, ANXA4 and ANXA6 are receptors of the serum factor fetuin-A on the surface of breast carcinoma cells. To determine which of these annexins is the bona fide cell surface receptor for fetuin-A, we have now examined the surface expression of ANXA2 and ANXA6 in the fetuin-A expressing hepatocellular carcinoma cell line HepG2 and in the invasive breast carcinoma cell line BT549. By glycerol gradient centrifugation of the post nuclear supernatants of HepG2 cells briefly cultivated at high extracellular Ca2+, we show that while ANXA2 predominantly associated with heavy membranes corresponding to the endogenous fetuin-A profile, the total membrane-associated ANXA6 on the contrary, diminished. Analysis of the EGTA-solubilized surface-associated proteins from HepG2 and BT549 cells revealed that ANXA6 is predominantly associated with the cell surface suggesting that it is externalized. Further analysis of the secreted proteins by differential velocity centrifugation and in particular the nanovesicle-associated (exosomal) secreted proteins confirmed that while secreted ANXA2 was barely detectable, ANXA6 was abundantly secreted via the exosomal pathway. From these data we hypothesized that the surface associated ANXA6 may be the major fetuin-A receptor on the surface of the invasive BT549 breast cancer cells and that it may be important in the growth, attachment and migration of these tumor cells. Using ANXA6 targeted shRNA we show that down regulation of ANXA6 inhibited the attachment of these cells to collagen Type I, Collagen Type IV and to the serum factor fetuin-A but attachment to and spreading on fibronectin was not affected. Based on the detection of vinculin and focal adhesion kinase, we demonstrate the complete absence of adhesion plaques in the ANXA6-depleted cells compared to the parental BT549 cells. This supports our observation that the ANXA6-depleted BT549 cells lost their ability to spread and hence are predominantly spindle-shaped; Moreover, the ANXA6-depleted BT549 cells proliferate faster than the parental cells; they grow in three-dimensional cultures as spheroid colonies resembling the ANXA6-negative MCF-10A acini rather than as stellate colonies produced by the parental cells. Finally, ANXA6 depletion in BT549 cells inhibited their migration and in vitro invasion of matrigel. Together our data demonstrate that ANXA6 expression in this metastatic breast cancer cells correlates with the invasive phenotype and that its association with the surface of these breast cancer cells modulates at least in part, attachment of these cells to the ECM and their overall morphology. Citation Information: Cancer Res 2009;69(23 Suppl):B52.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2009
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2017
    In:  Cancer Research Vol. 77, No. 13_Supplement ( 2017-07-01), p. 3928-3928
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 77, No. 13_Supplement ( 2017-07-01), p. 3928-3928
    Abstract: Patients with metastatic or end-stage breast cancer (BC) inevitably develop hypercalcemia, while up to 30% of BC patients develop cancer-induced hypercalcemia (CIH) in the absence of metastases or bone diseases. The commonly diagnosed mild increase in circulating calcium activates the calcium sensing receptor (CaSR) and has been shown to be associated with larger and more aggressive breast tumors in postmenopausal and premenopausal patients respectively. Whether differences in circulating calcium and/or specific inactivating CaSR variants play any role in disparities in BC outcomes remains unclear. DESIGN METHODS: We identified 199 BC cases and 384 age and genetic ancestry-matched controls with calcium assay and genotyping data from the Vanderbilt University DNA biorepository (BioVU) linked to de-identified electronic medical records. The linear mixed effects and codominant models were used to assess the relationship between inactivating CaSR mutations at rs1801725 (codon 986) and rs1801726 (codon 1011) and either circulating calcium levels or risk of high calcium-driven aggressive BC outcomes. RESULTS: We observed that circulating calcium levels were significantly higher in BC cases compared to control subjects (p=0.001) and interestingly, in subjects of African ancestry compared to Caucasians (p=0.001). The A986S mutant CaSR is common among Caucasians while the Q1011E mutant receptor is common among African Americans. However, only inactivating mutations at rs1801725 locus were significantly associated with higher calcium levels (p=0.006) and a higher (69%) risk of high calcium-driven aggressive BC outcomes compared to the wild type receptor. We also demonstrate that invasive BC cells are tolerant to sustained high calcium and that their adaptation to high calcium occurs via up-regulation of calcium-activated early response and malignancy-associated genes. CONCLUSION: These data suggest that inactivating CaSR polymorphisms at rs1801725 predispose BC patients to hypercalcemia and that high circulating calcium-driven aggressive disease outcomes occur via calcium modulated malignancy-associated genes such as MAGEC2/CT10. Citation Format: Diva Whalen, Li Wang, Sarrah Widatalla, Josiah Ochieng, Ann Richmond, Amos Sakwe. Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 3928. doi:10.1158/1538-7445.AM2017-3928
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2017
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2012
    In:  Cancer Research Vol. 72, No. 8_Supplement ( 2012-04-15), p. 5313-5313
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 72, No. 8_Supplement ( 2012-04-15), p. 5313-5313
    Abstract: Breast cancer frequently spreads to calcium-rich organs/metastatic sites such as skeletal tissues but the role of hypercalcemia in breast cancer progression remains poorly understood. While patients with metastatic or end-stage cancer are likely to become hypercalcemic, up to 30% of breast cancer patients develop cancer-induced hypercalcemia (CIH) in the absence of metastases or bone diseases. The resulting high extracellular ionized calcium (Ca2+) activates the calcium sensing receptor (CaSR) that not only promotes the proliferation of breast cancer cells but also the secretion of parathyroid hormone-related protein by the tumor cells. This suggests that CIH may promote both the vicious osteolytic cycle and breast cancer progression. In this study, we examined whether sustained hypercalcemia primes breast cancer cells for metastasis to high Ca2+ microenvironments. We demonstrate that sustained hypercalcemia enables Ca2+-sensitive non invasive breast cancer cells such as MCF-7 to become high Ca2+-adapted and that this adaptation is accompanied by increased motility and more aggressive growth (increased proliferation). Consistent with this observation, invasive and metastatic breast cancer cells are high Ca2+-adapted cells that efficiently grow over a wide range of Ca2+ concentrations (up to 10 mM). Interestingly, we also show that at high Ca2+ (5 mM) breast cancer cells expressing the Q1011E CaSR variant that is common among African Americans proliferate faster than those expressing the A986S CaSR variant that is common among Caucasians. These data suggest that differences in the adaptation of breast cancer cells to hypercalcemia due in part to the expression of distinct CaSR variants underlie the distinct race-related breast cancer outcomes. This work is funded by the following grants made available to JO: DOD-W81XWH-07-1-0254 and 1SC1CA134018-01 Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 5313. doi:1538-7445.AM2012-5313
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2012
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    Online Resource
    Online Resource
    Elsevier BV ; 2005
    In:  Biochemical and Biophysical Research Communications Vol. 338, No. 2 ( 2005-12), p. 1031-1036
    In: Biochemical and Biophysical Research Communications, Elsevier BV, Vol. 338, No. 2 ( 2005-12), p. 1031-1036
    Type of Medium: Online Resource
    ISSN: 0006-291X
    RVK:
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2005
    detail.hit.zdb_id: 1461396-7
    SSG: 12
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...